Search
Search Results
-
Radioiodine whole body scan pitfalls in differentiated thyroid cancer
Purposewhole body scan (WBS) performed following diagnostic or therapeutic administration of I-131 is useful in patients with differentiated thyroid...
-
Incidental detection of acquired unilateral nasolacrimal duct obstruction on I-131 whole body scan following I-131 therapy for thyroid cancer: a case report
BackgroundRadioactive iodine 131 (I-131) is used in the treatment of differentiated thyroid cancer after thyroidectomy; however, its accumulation in...
-
Augmentation of Radioiodine Uptake by Pulmonary Metastasis of Papillary Thyroid Carcinoma Treated with Dabrafenib and Trametinib
Redifferentiation therapy with Dabrafenib (a BRAF inhibitor) and Trametinib (a MEK inhibitor) restores radioiodine avidity of radioiodine-refractory...
-
False-positive radioiodine uptake after radioiodine treatment in differentiated thyroid cancer
Background and purposeFalse-positive radioiodine uptake can sometimes be observed with post-radioiodine treatment (RIT) whole body scanning....
-
Stimulated thyroglobulin and diagnostic 131-iodine whole-body scan as a predictor of distant metastasis and association with response to treatment in pediatric thyroid cancer patients
IntroductionDifferentiated thyroid carcinoma (DTC) is a rare oncological disease in the pediatric population, presenting with a more aggressive form....
-
Pulmonary sequestration: a rare cause of false-positive uptake in Iodine-131 whole-body scan
BackgroundHigh-dose radioactive iodine-131 (I-131) is generally used post-total or subtotal thyroidectomy in differentiated thyroid cancer (DTC)...
-
High thyroglobulin and negative whole-body scan: no long-term benefit of empiric radioiodine therapy
PurposeAround 10–27% of patients will present elevated thyroglobulin (Tg) levels and negative diagnostic whole-body scan (dxWBS) during...
-
Exophytic pancreatic lymphoepithelial cyst incidentally detected in a differentiated thyroid cancer patient on whole-body I-131 scan: a case report
BackgroundRadioiodine (I-131) whole-body scintigraphy (WBS) is a useful modality for identifying functionally preserved thyroid tissue and metastases...
-
Residual Thyroid Tissue on Postoperative Diagnostic 131 I Radioactive Whole-Body Scan After Surgery in Differentiated Thyroid Cancer: A Tertiary Referral Centre Experience
Residual thyroid tissue after total thyroidectomy in differentiated thyroid cancers is considered an independent risk factor for recurrence....
-
Additive value of 18FDG-PET/CT to positive 131I whole body scan in recurrent differentiated thyroid cancer patients with potential influence on treatment strategy: single Egyptian center experience
BackgroundYears ago the utility of of 18 F-fluorodeoxyglucose-positron emission tomography/computerized tomography ( 18 FDG-PET/CT) in differentiated...
-
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
PurposeRisk factors for develo** radioiodine refractory thyroid cancer (RAIR-TC) have rarely been analyzed. The purpose of the present study was to...
-
Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project
PurposeDosimetry is rarely performed for the treatment of differentiated thyroid cancer patients with Na[ 131 I]I (radioiodine), and information...
-
68Ga-DOTA-FAPI-04 PET/CT imaging in radioiodine-refractory differentiated thyroid cancer (RR-DTC) patients
ObjectiveThis study aimed to assess the potential of 68 Ga-DOTA-FAPI-04 PET/CT for the detection of the radioiodine-refractory differentiated thyroid...
-
Head-to-head comparison of [68Ga]Ga-DOTA.SA.FAPi with [18F]F-FDG PET/CT in radioiodine-resistant follicular-cell derived thyroid cancers
PurposeIn the context of radioiodine-resistant follicular-cell derived thyroid cancers (RAI-R-FCTC), [ 18 F]F-FDG PET/CT serves as a widely used and...
-
SPECT at the speed of PET: a feasibility study of CZT-based whole-body SPECT/CT in the post 177Lu-DOTATATE and 177Lu-PSMA617 setting
PurposeTo evaluate the feasibility of using the StarGuide (General Electric Healthcare, Haifa, Israel), a new generation multi-detector...
-
Pros and cons of an aggressive initial treatment with surgery and radioiodine treatment in minimally invasive follicular thyroid carcinoma
BackgroundCurrently, surgery alone is the gold standard treatment for minimally invasive follicular thyroid cancer (mi-FTC).
Case presentation ...
-
The value of the first postoperative diagnostic I-131 scan in patients with papillary thyroid carcinoma
ObjectiveTo explore the feasibility of the postoperative diagnostic 131 I whole-body planar scans (Dx-WBS) in papillary thyroid cancer (PTC)...
-
-
Scoring system and a simple nomogram for predicting radioiodine refractory differentiated thyroid cancer: a retrospective study
BackgroundDifferentiated thyroid carcinoma (DTC) originates from abnormal follicular cells and accounts for approximately 90–95% of thyroid...
-
Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised study
BackgroundLenvatinib is widely used to treat unresectable and advanced thyroid carcinomas. We aimed to determine whether 18 F-fluorodeoxyglucose...
